AMY-101
AMY-101 is a potent peptidic inhibitor targeting the central complement protein C3 with sub-nanomolar affinity. It has demonstrated promising anti-inflammatory efficacy in preclinical models of severe COVID-19 pneumonia characterized by systemic hyperinflammation, supporting its research use in complement-driven inflammatory diseases.
Product Specifications
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Molecular Weight
1789.11
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
